exevate-mf ointment 0.05 % w/w + 3.0 % w/w + 10.0 % w/w + 3.0 % w/w + 2.0 % w/w topical external ointments
ochoa laboratories limited - - betamethasone dipropionate + salicylic acid + urea + lactic acid + sodium lactate solution - topical external ointments - 0.05 % w/w + 3.0 % w/w + 10.0 % w/w + 3.0 % w/w + 2.0 % w/w
diprosone betamethasone 0.5 mg/g (as dipropionate) cream tube
organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: liquid paraffin; monobasic sodium phosphate dihydrate; phosphoric acid; white soft paraffin; cetomacrogol 1000; cetostearyl alcohol; sodium hydroxide; chlorocresol; purified water - indications as at 22 november 1995: diprosone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.
diprosalic 0.05/3 base %w/w ointment
b & s healthcare - betamethasone dipropionate, salicylic acid - ointment - 0.05/3 base %w/w - corticosteroids, potent, other combinations
diprosalic 0.05% w/w + 2% w/w scalp application
merck sharp & dohme ireland (human health) limited - betamethasone dipropionate; salicylic acid - cutaneous solution - 0.05 %w/w+2 percent weight/weight - corticosteroids, potent, other combinations; betamethasone
diprosalic 0.05%/3% ointment
organon pharma (uk) ltd - betamethasone dipropionate; salicylic acid - cutaneous ointment - 500microgram/1gram ; 30mg/1gram
beprosalic lotion
hoe pharmaceuticals sdn. bhd. - betamethasone dipropionate; salicylic acid/2-hydroxybenzoic acid -
diprosalic 0.05% w/w + 2% w/w scalp application
organon pharma (ireland) limited - betamethasone dipropionate; salicylic acid - cutaneous solution - 0.05 %w/w+2 percent weight/weight - corticosteroids, potent, other combinations; betamethasone
diprosalic 0.05% w/w + 2% w/w scalp application
imed healthcare ltd. - betamethasone dipropionate; salicylic acid - cutaneous solution - corticosteroids, potent, other combinations; betamethasone
diprosone betamethasone 0.5 mg/g (as dipropionate) ointment tube
organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; liquid paraffin - indications as at 22 november 1995: diprosone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.
diprosalic ointment
organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - ointment - salicylic acid 30 mg/g; betamethasone as dipropionate 0.5 mg/g - betamethasone - betamethasone - provides anti inflammatory, antipruritic, anti allergic and chronic hyperkeratotic and dry keratolytic activity in the topical management of subacute dermatoses responsive to corticosteroid therapy.